Table 2 Type of drugs used/injected by participants in focus group discussion of barriers and motivators to participation and retention in a cohort study in Iran, 2016
Type of drugs | Any drug usedc, n (%) | Any drug injected, n (%) | Main drug used/injected in the past 6 months, n (%) | |||
|---|---|---|---|---|---|---|
In the past 6 months | In the past 1 month | In the past 6 months | In the past 1 month | Usedc | Injected | |
Heroin/Crack | 26 (86.7) | 24 (80.0) | 29 (96.7) | 22 (73.3) | 23 (76.7) | 27 (90.0) |
Methamphetamine | 23 (76.7) | 18 (60.0) | 0 | 0 | 2 (6.7) | 0 |
Methadonea | 16 (53.3) | 9 (30.0) | 1 (3.3) | 0 | 2 (6.7) | 1 (3.3) |
Sedative drugs | 15 (50.0) | 6 (20.0) | 0 | 0 | 0 | 0 |
Codeine | 10 (33.3) | 4 (13.3) | 0 | 0 | 0 | 0 |
Opium/Opium extracts | 8 (26.7) | 2 (6.7) | 2 (6.7) | 2 (6.7) | 1 (3.3) | 1 (3.3) |
Hashish/Marijuana | 6 (20.0) | 1 (3.3) | 0 | 0 | 0 | 0 |
Nass (powdered tobacco) | 6 (20.0) | 5 (16.7) | 0 | 0 | 0 | 0 |
Alcohol | 3 (10.0) | 0 | 0 | 0 | 1 (3.3) | 0 |
Norjizak/Tamjizakb | 2 (6.7) | 2 (6.7) | 1 (3.3) | 0 | 1 (3.3) | 1 (3.3) |
Tramadol | 2 (6.7) | 2 (6.7) | 0 | 0 | 0 | 0 |
Cocaine | 1 (3.3) | 0 | 0 | 0 | 0 | 0 |
Ritalin | 1 (3.3) | 1 (3.3) | 0 | 0 | 0 | 0 |
Ecstasy (X) | 0 | 0 | 0 | 0 | 0 | 0 |
LSD/Acid | 0 | 0 | 0 | 0 | 0 | 0 |
Glue | 0 | 0 | 0 | 0 | 0 | 0 |
Others (not specified) | 1 (3.3) | 0 | 1 (3.3) | 0 | 0 | 0 |